Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Filed Feb 13, 2023 · 10-Q · 44 days after period end · 0001140361-23-006180
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $17.05M | $24.34M | $5.75M |
| Net Income | -$352.01M | -$284.54M | -$261.03M |
| EPS Diluted | -$0.49 | -$0.41 | -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Feb 13, 2023 · 44 d after period end
